EMEA-001693-PIP02-20

Table of contents

Key facts

Active substance
Reparixin
Therapeutic area
Infectious diseases
Decision number
P/0188/2021
PIP number
EMEA-001693-PIP02-20
Pharmaceutical form(s)
  • Tablet
  • Solution for infusion
Condition(s) / indication(s)
Treatment of coronavirus disease 2019 (COVID-2019)
Route(s) of administration
  • Oral use
  • Intravenous use
Contact for public enquiries
Dompé farmaceutici S.p.A.

E-mail: DAR@dompe.com
Tel: +39 0258383230

Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating